Cargando…
Efficacy of Vancomycin and Meropenem in Central Nervous System Infections in Children and Adults: Current Update
The current antimicrobial therapy of bacterial infections of the central nervous system (CNS) in adults and pediatric patients is faced with many pitfalls as the drugs have to reach necessary levels in serum and cross the blood-brain barrier. Furthermore, several studies report that different factor...
Autores principales: | Schneider, Franziska, Gessner, André, El-Najjar, Nahed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868565/ https://www.ncbi.nlm.nih.gov/pubmed/35203776 http://dx.doi.org/10.3390/antibiotics11020173 |
Ejemplares similares
-
Repurposing of Chronically Used Drugs in Cancer Therapy: A Chance to Grasp
por: Hijazi, Mohamad Ali, et al.
Publicado: (2023) -
Comparison of Rates of Acute Kidney Injury with Vancomycin/Piperacillin-Tazobactam vs. Vancomycin/Meropenem Combination Therapy
por: Pernia, Sonia, et al.
Publicado: (2017) -
Synergistic effect of vancomycin combined with cefotaxime, imipenem, or meropenem against Staphylococcus aureus with reduced susceptibility to vancomycin
por: SRİSRATTAKARN, Arpasiri, et al.
Publicado: (2021) -
Population Pharmacokinetics of Vancomycin and Meropenem in Pediatric Extracorporeal Membrane Oxygenation Support
por: Zylbersztajn, Brenda, et al.
Publicado: (2021) -
Empirical cefepime+vancomycin versus ceftazidime+vancomycin versus meropenem+vancomycin in the treatment of healthcare-associated meningitis: results of the multicenter Ephesus study
por: Sipahi, Oguz Resat, et al.
Publicado: (2023)